These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6949468)

  • 1. Pathophysiological considerations in selecting vasodilator therapy for CHF.
    Cohn JN
    Acta Med Scand Suppl; 1981; 652():93-7. PubMed ID: 6949468
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute hemodynamic responses to vasodilator therapy in congestive heart failure.
    Ribner HS; Bresnahan D; Hsieh AM; Silverman R; Tommaso C; Coath A; Askenazi J
    Prog Cardiovasc Dis; 1982; 25(1):1-42. PubMed ID: 6287524
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms and quantitative assessment of drug effects on cardiac output with a new model of the circulation.
    Greenway CV
    Pharmacol Rev; 1981 Dec; 33(4):213-51. PubMed ID: 7041140
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular effects of vasodilator therapy for pulmonary arterial hypertension.
    Rubin LJ
    Clin Chest Med; 1983 May; 4(2):309-19. PubMed ID: 6342925
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological aspects on the treatment of CHF.
    Andersson KE
    Acta Med Scand Suppl; 1981; 652():69-91. PubMed ID: 6120616
    [No Abstract]   [Full Text] [Related]  

  • 6. Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise.
    Krombach RS; Clair MJ; Hendrick JW; Mukherjee R; Houck WV; Hebbar L; Kribbs SB; Dodd MG; Spinale FG
    Am J Cardiol; 1999 Aug; 84(4A):3L-15L. PubMed ID: 10480440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathomechanisms of heart failure].
    Urbaszek W
    Z Arztl Fortbild (Jena); 1993; 87(8 Suppl 4):1-4. PubMed ID: 8105608
    [No Abstract]   [Full Text] [Related]  

  • 8. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
    Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
    J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems of chronic heart failure].
    Tkaczewski W
    Pol Arch Med Wewn; 1992; 88(2-3):200-6. PubMed ID: 1492027
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symposium on vasodilator and inotropic therapy of heart failure. Symposium perspective.
    Mason DT
    Am J Med; 1978 Jul; 65(1):101-5. PubMed ID: 356597
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current treatment concepts in chronic heart failure].
    Nikolov GT
    Vutr Boles; 1981; 20(2):16-25. PubMed ID: 6266162
    [No Abstract]   [Full Text] [Related]  

  • 13. Unloading the heart in congestive heart failure.
    Cohn JN
    Am J Med; 1984 Aug; 77(2A):67-70. PubMed ID: 6383033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator and inotropic therapy for heart failure.
    DiPalma JR
    Am Fam Physician; 1985 Jun; 31(6):177-80. PubMed ID: 4013962
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary vasodilation in acute and chronic heart failure: empiricism and evidence.
    Guglin M
    Curr Heart Fail Rep; 2011 Sep; 8(3):219-25. PubMed ID: 21556702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists in heart failure?].
    Drexler H; Just H
    Klin Wochenschr; 1986 Oct; 64(20):993-1002. PubMed ID: 3784463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac failure XIV. Treatment by modification of circulatory dynamics.
    Cohn JN
    Hosp Pract (Off Ed); 1984 Aug; 19(8):37-52. PubMed ID: 6430933
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacology of vasodilator drugs; recent developments].
    van Zwieten PA; van Meel JC; de Jonge A; Kalkman HO; Timmermans PB
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():78-86. PubMed ID: 7187165
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heart failure: from physiopathology to treatment. II. Treatment].
    Batlouni M
    Arq Bras Cardiol; 1991 Aug; 57(2):151-67. PubMed ID: 1823774
    [No Abstract]   [Full Text] [Related]  

  • 20. Congestive cardiomyopathy: therapeutic approach.
    Chatterjee K; Stern L
    Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.